Regulatory T cells (Treg), as members of CD4+ T cells, have garnered extensive attention in
the research of tumor progression. Treg cells have the function of inhibiting the immune …

Background The optimal local treatment for HCC with tumor diameter≥ 5 cm is not well
established. This research evaluated the effectiveness of external beam radiation therapy …

Hepatocellular carcinoma (HCC) is a malignant and deadly form of liver cancer with limited
treatment options. Transcatheter arterial chemoembolization, a procedure that delivers …

Background Hepatocellular carcinoma (HCC) is a prevailing cancer affecting human health.
M2 macrophages are essential in mediating immune responses in tumors. This study …

Advanced hepatocellular carcinoma (HCC) is a formidable public health problem with
limited curable treatment options. Axitinib, an oral tyrosine kinase inhibitor, is a potent and …

Background Atezolizumab plus bevacizumab and lenvatinib are the current first-line
systematic therapy for unresectable hepatocellular carcinoma (uHCC). However, the …

Abstract N 6‐Methyladenosine (m6A) is a important process regulating gene expression
post‐transcriptionally. Programmed death ligand 1 (PD‐L1) is a major immune inhibitive …

Clinical and Regulatory Affairs, Arcellx Inc., Redwood City, CA, USA Correspondence to:
Anand Rotte. Clinical and Regulatory Affairs, Arcellx Inc., Redwood City, CA, USA. Email …

Programmed cell death-ligand 1 (PD-L1) has a significant role in tumor progression and
metastasis, facilitating tumor cell evasion from immune surveillance. PD-L1 can be detected …

Background Whether irAEs can predict the efficacy of PD-1 inhibitors in cholangiocarcinoma
(CCA) has not been assessed. Therefore, this study aims to investigate the correlation …